About CatalystAdmin

This author has not yet filled in any details.
So far CatalystAdmin has created 113 blog entries.

Innovation and FDA’s Regulatory Frameworks: Catalyst Co-Authors Explore How the Coming Data Shift Will Impact Medical Product Regulation in Therapeutic Innovation & Regulatory Science Article

Given rapid advances in technology and our understanding of disease, [...]

Innovation and FDA’s Regulatory Frameworks: Catalyst Co-Authors Explore How the Coming Data Shift Will Impact Medical Product Regulation in Therapeutic Innovation & Regulatory Science Article 2017-11-25T20:28:38+00:00

Former FDA Associate Commissioner Jill Hartzler Warner Joins Catalyst Team, Expanding the Firm’s Expertise in Regenerative Medicine, Rare Disease Drug Development and Combination Product Regulation

Press release Washington, DC – Catalyst Healthcare Consulting is pleased [...]

Former FDA Associate Commissioner Jill Hartzler Warner Joins Catalyst Team, Expanding the Firm’s Expertise in Regenerative Medicine, Rare Disease Drug Development and Combination Product Regulation 2017-11-25T20:28:58+00:00

Trump’s Deregulatory Agenda: What It Could Mean For Biopharma & Medtech Companies

Pharmaceutical Online- What do President Trump’s deregulatory executive orders mean [...]

Trump’s Deregulatory Agenda: What It Could Mean For Biopharma & Medtech Companies 2018-05-24T20:23:48+00:00

A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?

The Pink Sheet— In this analysis piece, The Pink Sheet [...]

A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff? 2018-05-24T20:27:41+00:00